These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9831966)

  • 1. Clinical importance of non-genetic and genetic cytochrome P450 function tests in liver disease.
    Tanaka E
    J Clin Pharm Ther; 1998 Jun; 23(3):161-70. PubMed ID: 9831966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of 7-benzyloxy-4-trifluoromethyl-coumarin by human hepatic cytochrome P450 isoforms.
    Renwick AB; Surry D; Price RJ; Lake BG; Evans DC
    Xenobiotica; 2000 Oct; 30(10):955-69. PubMed ID: 11315104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450: genetic polymorphism and drug interactions.
    Belpaire FM; Bogaert MG
    Acta Clin Belg; 1996; 51(4):254-60. PubMed ID: 8858891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the human liver cytochrome P450 isoenzymes responsible for the 5-methylhydroxylation of the novel anti-fibrotic drug AKF-PD.
    He X; Luo X; Liu Z; Hu G; Cheng Z
    Xenobiotica; 2011 Oct; 41(10):844-50. PubMed ID: 21679010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of interaction of milnacipran with the cytochrome p450 isoenzymes frequently involved in the metabolism of antidepressants.
    Puozzo C; Lens S; Reh C; Michaelis K; Rosillon D; Deroubaix X; Deprez D
    Clin Pharmacokinet; 2005; 44(9):977-88. PubMed ID: 16122284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver disease selectively modulates cytochrome P450--mediated metabolism.
    Frye RF; Zgheib NK; Matzke GR; Chaves-Gnecco D; Rabinovitz M; Shaikh OS; Branch RA
    Clin Pharmacol Ther; 2006 Sep; 80(3):235-45. PubMed ID: 16952490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of carteolol by cDNA-expressed human cytochrome P450.
    Kudo S; Uchida M; Odomi M
    Eur J Clin Pharmacol; 1997; 52(6):479-85. PubMed ID: 9342584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
    Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT
    Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 metabolic dealkylation of nine N-nitrosodialkylamines by human liver microsomes.
    Bellec G; Dréano Y; Lozach P; Ménez JF; Berthou F
    Carcinogenesis; 1996 Sep; 17(9):2029-34. PubMed ID: 8824531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic disulfiram administration on the activities of CYP1A2, CYP2C19, CYP2D6, CYP2E1, and N-acetyltransferase in healthy human subjects.
    Frye RF; Branch RA
    Br J Clin Pharmacol; 2002 Feb; 53(2):155-62. PubMed ID: 11851639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes.
    Rifkind AB; Lee C; Chang TK; Waxman DJ
    Arch Biochem Biophys; 1995 Jul; 320(2):380-9. PubMed ID: 7625847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.
    Kharasch ED; Thummel KE
    Anesthesiology; 1993 Oct; 79(4):795-807. PubMed ID: 8214760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fondaparinux sodium is not metabolised in mammalian liver fractions and does not inhibit cytochrome P450-mediated metabolism of concomitant drugs.
    Lieu C; Shi J; Donat F; Van Horn R; Brian W; Newton J; Delbressine L; Vos R
    Clin Pharmacokinet; 2002; 41 Suppl 2():19-26. PubMed ID: 12383041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of (S)-mephenytoin and proguanil oxidation in vitro: contribution of several CYP isoforms.
    Coller JK; Somogyi AA; Bochner F
    Br J Clin Pharmacol; 1999 Aug; 48(2):158-67. PubMed ID: 10417492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2.
    Yoshimoto K; Echizen H; Chiba K; Tani M; Ishizaki T
    Br J Clin Pharmacol; 1995 Apr; 39(4):421-31. PubMed ID: 7640150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of Zaleplon by human hepatic microsomal cytochrome P450 isoforms.
    Renwick AB; Mistry H; Ball SE; Walters DG; Kao J; Lake BG
    Xenobiotica; 1998 Apr; 28(4):337-48. PubMed ID: 9604298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nilvadipine, a dihydropyridine calcium antagonist, on cytochrome P450 activities in human hepatic microsomes.
    Niwa T; Shiraga T; Hashimoto T; Kagayama A
    Biol Pharm Bull; 2004 Mar; 27(3):415-7. PubMed ID: 14993813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytochrome P450-dependent drug oxidation activities in liver microsomes of various animal species including rats, guinea pigs, dogs, monkeys, and humans.
    Shimada T; Mimura M; Inoue K; Nakamura S; Oda H; Ohmori S; Yamazaki H
    Arch Toxicol; 1997; 71(6):401-8. PubMed ID: 9195021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo function tests of hepatic drug-oxidizing capacity in patients with liver disease.
    Tanaka E; Breimer DD
    J Clin Pharm Ther; 1997 Aug; 22(4):237-49. PubMed ID: 9548204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cefixime and cefdinir, oral cephalosporins, on cytochrome P450 activities in human hepatic microsomes.
    Niwa T; Shiraga T; Hashimoto T; Kagayama A
    Biol Pharm Bull; 2004 Jan; 27(1):97-9. PubMed ID: 14709907
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.